No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Clinical Trials, Phase III as Topic
-
Drug Approval
-
Humans
-
Interleukin-17 / antagonists & inhibitors*
-
Psoriasis / drug therapy*
-
Psoriasis / pathology
-
United States
-
United States Food and Drug Administration
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Interleukin-17
-
secukinumab